Report cover image

Global Poultry Medicine/Pharmaceuticals Market Size, Share & Trends Analysis by Product (Vaccines, Antibiotics, Probiotics, Immune Boosters), by Disease Indication (Newcastle Disease, Avian Influenza, Infectious Bronchitis), by Route of Administration (Or

Publisher Factview Research
Published Oct 03, 2025
Length 285 Pages
SKU # FAVR20464218

Description

The global poultry medicine/pharmaceuticals market was valued at USD 5.01 billion in 2024 and is anticipated to grow at a CAGR of 6.2% during the forecast period of 2025-2034. The expansion of the market is largely driven by increased poultry consumption, population growth, technological advancements in disease prevention, and rising concerns regarding food safety and sustainability in poultry farming.

The surging demand for protein-rich foods, particularly poultry meat and eggs, has fueled the expansion of poultry farming, necessitating robust disease prevention and treatment solutions. Newcastle disease, Avian Influenza, and Coccidiosis remain key challenges in poultry farming, driving demand for effective vaccines, antibiotics, and immune boosters. The stringent regulations on antibiotic use in livestock have further accelerated the adoption of probiotics, vaccines, and alternative treatments, promoting sustainable poultry production.

Furthermore, advancements in in ovo vaccination technology have revolutionized large-scale immunization, reducing labor costs and enhancing disease control. The growth of industrial poultry farming in emerging markets, particularly in Asia-Pacific, Latin America, and Africa, has created substantial opportunities for pharmaceutical innovations tailored for large-scale poultry operations.

Growing Need for Disease Prevention to Drive Market Growth- The poultry industry faces substantial risks from highly contagious poultry diseases, prompting extensive vaccination programs to mitigate economic losses. Vaccines account for the largest market share due to their necessity in preventing Newcastle disease, Avian Influenza, and Infectious Bronchitis, which can devastate poultry farms and impact trade. The increasing regulatory restrictions on antibiotics in food production have further propelled the demand for alternative disease prevention methods, such as probiotics and immune boosters.

Recent innovations, such as thermostable and vector-based vaccines, offer improved efficacy, while the widespread adoption of oral administration methods ensures efficient mass treatment for large poultry populations. The shift toward precision medicine in poultry healthcare, coupled with government-mandated vaccination programs, is expected to drive continued market expansion.

Regional Market Insights- The Asia-Pacific region dominates the poultry medicine/pharmaceuticals market, driven by high poultry consumption, rapid urbanization, and increasing disposable incomes in countries like China, India, and Indonesia. The rise of commercial poultry farms and the prevalence of poultry diseases in the region have led to significant investments in preventive healthcare and vaccination strategies.

In North America and Europe, stringent regulatory policies on antibiotic usage and the adoption of sustainable farming practices have fueled the demand for probiotics and non-antibiotic alternatives. Meanwhile, Latin America and Africa present growth opportunities due to the increasing demand for affordable protein sources, leading to the expansion of poultry farming and disease management initiatives.

Key Poultry Medicine/Pharmaceutical Companies
  • MSD Animal Health (US)
  • Elanco Animal Health (US)
  • Boehringer Ingelheim (Germany)
  • Ceva Santé Animale (France)
  • Zoetis Services LLC (US)
  • Virbac (France)
  • Phibro Animal Health (US)
  • HIPRA (Spain)
  • Vetoquinol (France)
  • Biovet (Bulgaria)
  • Huvepharma (Bulgaria)
  • Indian Immunologicals Ltd (India)
  • Anicon GmbH (Germany)
  • IDEXX Laboratories (US)
  • Kemin Industries (US)
The Detailed Segments and Sub-segments of the Market are Explained Below:

By Product:
  • Vaccines
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Antibiotics
  • Tetracyclines
  • Macrolides
  • Beta-lactams
  • Sulfonamides
  • Probiotics & Prebiotics
  • Immune Boosters & Growth Enhancers
  • Parasiticides
  • Other Pharmaceuticals
By Disease Indication:
  • Newcastle Disease
  • Avian Influenza
  • Infectious Bronchitis
  • Coccidiosis
  • Fowl Cholera
  • Marek’s Disease
  • Other Poultry Diseases
By Route of Administration:
  • Oral (Feed & Water)
  • Injectable
  • Topical
  • Other Routes
By Animal Type:
  • Chickens
  • Turkeys
  • Ducks
  • Other Poultry
By Region:

North America
  • U.S.
  • Canada
  • Mexico
Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Netherlands
Asia-Pacific
  • China
  • India
  • Japan
  • Indonesia
  • Australia
  • South Korea
Latin America
  • Brazil
  • Argentina
  • Mexico
Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
Years considered for the study are as follows:
  • Historical year – 2022
  • Base year – 2024
  • Forecast period – 2024 to 2034
Key Takeaways:
  • Market Estimates & Forecast for 10 years (2022-2034).
  • Annualized revenue and regional-level analysis for each market segment.
  • Detailed geographical landscape with country-level analysis of major regions.
  • Competitive landscape with market share insights from leading players.
  • Analysis of key business strategies and recommendations for future market positioning.
  • Competitive structure evaluation with SWOT analysis of major companies.
  • Demand-side and supply-side assessment of the market.

Table of Contents

285 Pages
Chapter 1. Global Poultry Medicine/Pharmaceuticals Market Executive Summary
1.1. Global Poultry Medicine/Pharmaceuticals Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Disease Indication
1.3.3. By Route of Administration
1.3.4. By Animal Type
1.4. Key Trends
1.5. Recession Impact
1.6. Industry Metrics
1.7. Investment Analysis
1.8 .Investment Rationale
1.9. Analyst Recommendation & Conclusion
Chapter 2. Global Poultry Medicine/Pharmaceuticals Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Poultry Medicine/Pharmaceuticals Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Poultry Consumption and Demand for Animal Protein
3.1.2. Rising Prevalence of Poultry Diseases and Need for Disease Prevention
3.1.3. Regulatory Restrictions on Antibiotics in Livestock Production
3.2. Market Challenges
3.2.1. High Cost of Poultry Vaccines and Disease Management
3.2.2. Stringent Government Regulations on Poultry Drug Approvals
3.3. Market Opportunities
3.3.1. Growing Investments in Poultry Healthcare & R&D for Disease Prevention
3.3.2. Expansion of Poultry Farming in Emerging Markets
3.3.3. Increasing Adoption of Probiotics and Natural Alternatives for Disease Control
Chapter 4. Global Poultry Medicine/Pharmaceuticals Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends in the Poultry Pharmaceuticals Industry
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Poultry Medicine/Pharmaceuticals Market Size & Forecasts by Product (2024-2034)
5.1. Segment Dashboard
5.2. Global Poultry Medicine/Pharmaceuticals Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Vaccines
5.2.2. Antibiotics
5.2.3. Probiotics & Prebiotics
5.2.4. Immune Boosters & Growth Enhancers
5.2.5. Parasiticides
5.2.6. Other Pharmaceuticals
Chapter 6. Global Poultry Medicine/Pharmaceuticals Market Size & Forecasts by Disease Indication (2024-2034)
6.1. Segment Dashboard
6.2. Global Poultry Medicine/Pharmaceuticals Market: Disease Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Newcastle Disease
6.2.2. Avian Influenza
6.2.3. Infectious Bronchitis
6.2.4. Coccidiosis
6.2.5. Fowl Cholera
6.2.6. Marek’s Disease
6.2.7. Other Poultry Diseases
Chapter 7. Global Poultry Medicine/Pharmaceuticals Market Size & Forecasts by Route of Administration (2024-2034)
7.1. Segment Dashboard
7.2. Global Poultry Medicine/Pharmaceuticals Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Oral (Feed & Water)
7.2.2. Injectable
7.2.3. Topical
7.2.4. Other Routes
Chapter 8. Global Poultry Medicine/Pharmaceuticals Market Size & Forecasts by Animal Type (2024-2034)
8.1. Segment Dashboard
8.2. Global Poultry Medicine/Pharmaceuticals Market: Animal Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Chickens
8.2.2. Turkeys
8.2.3. Ducks
8.2.4. Other Poultry
Chapter 9. Global Poultry Medicine/Pharmaceuticals Market Size & Forecasts by Region (2024-2034)
9.1. North America Poultry Medicine/Pharmaceuticals Market
9.1.1. U.S. Market Breakdown
9.1.2. Canada Market Breakdown
9.1.3. Mexico Market Breakdown
9.2. Europe Poultry Medicine/Pharmaceuticals Market
9.2.1. Germany Market Breakdown
9.2.2. U.K. Market Breakdown
9.2.3. France Market Breakdown
9.2.4. Italy Market Breakdown
9.2.5. Spain Market Breakdown
9.2.6. Netherlands Market Breakdown
9.3. Asia-Pacific Poultry Medicine/Pharmaceuticals Market
9.3.1. China Market Breakdown
9.3.2. India Market Breakdown
9.3.3. Japan Market Breakdown
9.3.4. Indonesia Market Breakdown
9.3.5. Australia Market Breakdown
9.3.6. South Korea Market Breakdown
9.4. Latin America Poultry Medicine/Pharmaceuticals Market
9.4.1. Brazil Market Breakdown
9.4.2. Argentina Market Breakdown
9.4.3. Mexico Market Breakdown
9.5. Middle East & Africa Poultry Medicine/Pharmaceuticals Market
9.5.1. South Africa Market Breakdown
9.5.2. Saudi Arabia Market Breakdown
9.5.3. UAE Market Breakdown
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. MSD Animal Health
10.1.2. Elanco Animal Health
10.1.3. Boehringer Ingelheim
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. MSD Animal Health
10.3.2. Elanco Animal Health
10.3.3. Boehringer Ingelheim
10.3.4. Ceva Santé Animale
10.3.5. Zoetis Services LLC
10.3.6. Virbac
10.3.7. Phibro Animal Health
10.3.8. HIPRA
10.3.9. Vetoquinol
10.3.10. Huvepharma
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us